| Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article; Review
- Language: English
- [In Vitro Cell Dev Biol Anim] 2024 May 07. <i>Date of Electronic Publication: </i>2024 May 07.
- References: Abraham JA, Whang JL, Tumolo A, Mergia A, Friedman J, Gospodarowicz D, Fiddes JC (1986) Human basic fibroblast growth factor: nucleotide sequence and genomic organization. Embo j 5:2523–2528. (PMID: 3780670116714810.1002/j.1460-2075.1986.tb04530.x) ; Akutsu T, Kanno K, Okada S, Ohdaira H, Suzuki Y, Urashima M (2021) Effect of vitamin D supplements on relapse of digestive tract cancer with tumor stromal immune response: a secondary analysis of the AMATERASU Randomized Clinical Trial. Cancers (Basel) 13:4708. ; Albino AP, Davis BM, Nanus DM (1991) Induction of growth factor RNA expression in human malignant melanoma: markers of transformation. Cancer Res 51:4815–4820. (PMID: 1716514) ; Andaloussi S, Mäger I, Breakefield XO, Wood MJ (2013) Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov 12:347–357. (PMID: 2358439310.1038/nrd3978) ; Baird A, Ling N (1987) Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase-like enzymes in the neovascular response. Biochem Biophys Res Commun 142:428–435. (PMID: 243409410.1016/0006-291X(87)90292-0) ; Beer HD, Bittner M, Niklaus G, Munding C, Max N, Goppelt A, Werner S (2005) The fibroblast growth factor binding protein is a novel interaction partner of FGF-7, FGF-10 and FGF-22 and regulates FGF activity: implications for epithelial repair. Oncogene 24:5269–5277. (PMID: 1580617110.1038/sj.onc.1208560) ; Begum S, Zhang Y, Shintani T, Toratani S, Sato JD, Okamoto T (2007) Immunohistochemical expression of heparin-binding protein 17/fibroblast growth factor-binding protein-1 (HBp17/FGFBP-1) as an angiogenic factor in head and neck tumorigenesis. Oncol Rep 17:591–596. (PMID: 17273738) ; Bennett MR, Gibson DF, Schwartz SM, Tait JF (1995) Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine. Circ Res 77:1136–1142. (PMID: 758622610.1161/01.RES.77.6.1136) ; Bikle DD (2021) Vitamin D: production, metabolism and mechanisms of action. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP (eds) Endotext. MDText.com, Inc. Copyright © 2000–2024, MDText.com, Inc., South Dartmouth (MA). ; Bochen F, Balensiefer B, Körner S, Bittenbring JT, Neumann F, Koch A, Bumm K, Marx A, Wemmert S, Papaspyrou G, Zuschlag D, Kühn JP, Al Kadah B, Schick B, Linxweiler M (2018) Vitamin D deficiency in head and neck cancer patients - prevalence, prognostic value and impact on immune function. Oncoimmunology 7:e1476817. (PMID: 30228945614058810.1080/2162402X.2018.1476817) ; Burgess WH, Maciag T (1989) The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 58:575–606. (PMID: 254985710.1146/annurev.bi.58.070189.003043) ; Burland TG, Bailey J, Adam L, Mukhopadhyay MJ, Dove WF, Pallotta D (1992) Transient expression in Physarum of a chloramphenicol acetyltransferase gene under the control of actin gene promoters. Curr Genet 21:393–398. (PMID: 152586510.1007/BF00351700) ; Buss JE, Kudlow JE, Lazar CS, Gill GN (1982) Altered epidermal growth factor (EGF)-stimulated protein kinase activity in variant A431 cells with altered growth responses to EGF. Proc Natl Acad Sci U S A 79:2574–2578. (PMID: 628353534624210.1073/pnas.79.8.2574) ; Chen Y, Liu W, Sun T, Huang Y, Wang Y, Deb DK, Yoon D, Kong J, Thadhani R, Li YC (2013) 1,25-Dihydroxyvitamin D promotes negative feedback regulation of TLR signaling via targeting microRNA-155-SOCS1 in macrophages. J Immunol 190:3687–3695. (PMID: 2343693610.4049/jimmunol.1203273) ; Colotta F, Jansson B, Bonelli F (2017) Modulation of inflammatory and immune responses by vitamin D. J Autoimmun 85:78–97. (PMID: 2873312510.1016/j.jaut.2017.07.007) ; Czubayko F, Liaudet-Coopman ED, Aigner A, Tuveson AT, Berchem GJ, Wellstein A (1997) A secreted FGF-binding protein can serve as the angiogenic switch in human cancer. Nat Med 3:1137–1140. (PMID: 933472710.1038/nm1097-1137) ; Folkman J, Hanahan D (1991) Switch to the angiogenic phenotype during tumorigenesis. Princess Takamatsu Symp 22:339–347. (PMID: 1726933) ; Gospodarowicz D, Jones KL, Sato G (1974) Purification of a growth factor for ovarian cells from bovine pituitary glands. Proc Natl Acad Sci U S A 71:2295–2299. (PMID: 452620838843910.1073/pnas.71.6.2295) ; Harris VK, Coticchia CM, List HJ, Wellstein A, Riegel AT (2000) Mitogen-induced expression of the fibroblast growth factor-binding protein is transcriptionally repressed through a non-canonical E-box element. J Biol Chem 275:28539–28548. (PMID: 1087160610.1074/jbc.M001677200) ; Harris VK, Liaudet-Coopman ED, Boyle BJ, Wellstein A, Riegel AT (1998) Phorbol ester-induced transcription of a fibroblast growth factor-binding protein is modulated by a complex interplay of positive and negative regulatory promoter elements. J Biol Chem 273:19130–19139. (PMID: 966809810.1074/jbc.273.30.19130) ; Hatakeyama S, Nagashima S, Imai N, Takahashi K, Ishihara J, Sugita A, Nihei T, Saito H, Takahashi F, Kubodera N (2007) Synthesis and biological evaluation of a 3-positon epimer of 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3 (ED-71). J Steroid Biochem Mol Biol 103:222–226. (PMID: 1720799110.1016/j.jsbmb.2006.12.025) ; Herlyn M, Clark WH, Rodeck U, Mancianti ML, Jambrosic J, Koprowski H (1987) Biology of tumor progression in human melanocytes. Lab Invest 56:461–474. (PMID: 3553733) ; Higaki M, Shintani T, Hamada A, Rosli SNZ, Okamoto T (2020) Eldecalcitol (ED-71)-induced exosomal miR-6887-5p suppresses squamous cell carcinoma cell growth by targeting heparin-binding protein 17/fibroblast growth factor-binding protein-1 (HBp17/FGFBP-1). In Vitro Cell Dev Biol Anim 56:222–233. (PMID: 3218560810.1007/s11626-020-00440-x) ; Ito N, Yamasaki S, Shintani T, Matsui K, Obayashi F, Koizumi K, Tani R, Yanamoto S, Okamoto T (2023) Tumor-infiltrating CD45RO(+) memory cells are associated with favorable prognosis in oral squamous cell carcinoma patients. Cancers (Basel) 15:2221. ; Itoh N, Ornitz DM (2011) Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. J Biochem 149:121–130. (PMID: 2094016910.1093/jb/mvq121) ; Klagsbrun M (1989) The fibroblast growth factor family: structural and biological properties. Prog Growth Factor Res 1:207–235. (PMID: 249126310.1016/0955-2235(89)90012-4) ; Koll L, Gül D, Elnouaem MI, Raslan H, Ramadan OR, Knauer SK, Strieth S, Hagemann J, Stauber RH, Khamis A (2023) Exploiting vitamin D receptor and its ligands to target squamous cell carcinomas of the head and neck. Int J Mol Sci 24:4675. ; Krämer-Albers EM, Hill AF (2016) Extracellular vesicles: interneural shuttles of complex messages. Curr Opin Neurobiol 39:101–107. (PMID: 2718338110.1016/j.conb.2016.04.016) ; Lametsch R, Rasmussen JT, Johnsen LB, Purup S, Sejrsen K, Petersen TE, Heegaard CW (2000) Structural characterization of the fibroblast growth factor-binding protein purified from bovine prepartum mammary gland secretion. J Biol Chem 275:19469–19474. (PMID: 1086701610.1074/jbc.M002550200) ; Li C, Shintani S, Terakado N, Klosek SK, Ishikawa T, Nakashiro K, Hamakawa H (2005) Microvessel density and expression of vascular endothelial growth factor, basic fibroblast growth factor, and platelet-derived endothelial growth factor in oral squamous cell carcinomas. Int J Oral Maxillofac Surg 34:559–565. (PMID: 1605387810.1016/j.ijom.2004.10.016) ; Liu X, Shi S, Chen J-H, Wu D, Kan M, Myoken Y, Okamoto T, Sato JD (2002) Human fibroblast growth factor-binding protein HBp17 enhances the tumorigenic potential of immortalized squamous epithelial cells. In Shirahata S, Teruya K, Katakura Y (eds) Animal cell technology: basic & applied aspects: Proceedings of the Thirteenth Annual Meeting of the Japanese Association for Animal Cell Technology (JAACT), Fukuoka-Karatsu, November 16–21, 2000. Springer Netherlands, Dordrecht, pp. 343–352. ; Mäkitie A, Tuokkola I, Laurell G, Mäkitie O, Olsen K, Takes RP, Florek E, Szyfter K, Sier CFM, Ferlito A (2020) Vitamin D in head and neck cancer: a systematic review. Curr Oncol Rep 23:5. (PMID: 33216252767933610.1007/s11912-020-00996-7) ; Mongiat M, Otto J, Oldershaw R, Ferrer F, Sato JD, Iozzo RV (2001) Fibroblast growth factor-binding protein is a novel partner for perlecan protein core. J Biol Chem 276:10263–10271. (PMID: 1114821710.1074/jbc.M011493200) ; Morita M, Okuyama M, Akutsu T, Ohdaira H, Suzuki Y, Urashima M (2021) Vitamin D supplementation regulates postoperative serum levels of PD-L1 in patients with digestive tract cancer and improves survivals in the highest quintile of PD-L1: a post hoc analysis of the AMATERASU Randomized Controlled Trial. Nutrients 13:1987. ; Munem F, Thianhlun PCK, Anderson PH, Stringer AM (2023) Vitamin D is a potential treatment for the management of gastrointestinal mucositis. Curr Opin Support Palliat Care. https://doi.org/10.1097/spc.0000000000000651. (PMID: 10.1097/spc.000000000000065137276064) ; Myoken Y, Myoken Y, Okamoto T, Sato JD, Takada K (1994) Immunocytochemical localization of fibroblast growth factor-1 (FGF-1) and FGF-2 in oral squamous cell carcinoma (SCC). J Oral Pathol Med 23:451–456. (PMID: 753222010.1111/j.1600-0714.1994.tb00443.x) ; Myoken Y, Myoken Y, Okamoto T, Sato JD, Takada K (1995) Effect of fibroblast growth factor-1 on the three-dimensional growth and morphogenesis of human salivary gland epithelial cells embedded in collagen gels. In Vitro Cell Dev Biol Anim 31:84–86. (PMID: 773557010.1007/BF02633966) ; Okamoto T, Tanaka Y, Kan M, Sakamoto A, Takada K, Sato JD (1996a) Expression of fibroblast growth factor binding protein HBp17 in normal and tumor cells. In Vitro Cell Dev Biol Anim 32:69–71. (PMID: 890711710.1007/BF02723035) ; Okamoto T, Tani R, Yabumoto M, Sakamoto A, Takada K, Sato GH, Sato JD (1996b) Effects of insulin and transferrin on the generation of lymphokine-activated killer cells in serum-free medium. J Immunol Methods 195:7–14. (PMID: 881431410.1016/0022-1759(96)00081-6) ; Pu Y, Zhu G, Xu Y, Zheng S, Tang B, Huang H, Wu IXY, Huang D, Liu Y, Zhang X (2021) Association between vitamin D exposure and head and neck cancer: a systematic review with meta-analysis. Front Immunol 12:627226. (PMID: 33732250795980010.3389/fimmu.2021.627226) ; Pucci F, Garris C, Lai CP, Newton A, Pfirschke C, Engblom C, Alvarez D, Sprachman M, Evavold C, Magnuson A, von Andrian UH, Glatz K, Breakefield XO, Mempel TR, Weissleder R, Pittet MJ (2016) SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions. Science 352:242–246. (PMID: 26989197496063610.1126/science.aaf1328) ; Rols MP, Delteil C, Golzio M, Dumond P, Cros S, Teissie J (1998) In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol 16:168–171. (PMID: 948752410.1038/nbt0298-168) ; Rosli SN, Shintani T, Hayashido Y, Toratani S, Usui E, Okamoto T (2013) 1α,25OH2D3 down-regulates HBp17/FGFBP-1 expression via NF-κB pathway. J Steroid Biochem Mol Biol 136:98–101. (PMID: 2310411610.1016/j.jsbmb.2012.10.011) ; Rosli SN, Shintani T, Toratani S, Usui E, Okamoto T (2014) 1α,25(OH) 2 D 3 inhibits FGF-2 release from oral squamous cell carcinoma cells through down-regulation of HBp17/FGFBP-1. In Vitro Cell Dev Biol Anim 50:802–806. (PMID: 2493835710.1007/s11626-014-9787-5) ; Saito H, Harada S (2014) Eldecalcitol replaces endogenous calcitriol but does not fully compensate for its action in vivo. J Steroid Biochem Mol Biol 144(Pt A):189–196. (PMID: 2429140110.1016/j.jsbmb.2013.11.013) ; Sato JD, Kawamoto T, Okamoto T (1987) Cholesterol requirement of P3–X63-Ag8 and X63-Ag8.653 mouse myeloma cells for growth in vitro. J Exp Med 165:1761–1766. (PMID: 358525110.1084/jem.165.6.1761) ; Schulze-Osthoff K, Risau W, Vollmer E, Sorg C (1990) In situ detection of basic fibroblast growth factor by highly specific antibodies. Am J Pathol 137:85–92. (PMID: 16954841877697) ; Seno M, Masago A, Nishimura A, Tada H, Kosaka M, Sasada R, Igarashi K, Seno S, Yamada H (1998) BALB/c 3T3 cells co-expressing FGF-2 and soluble FGF receptor acquire tumorigenicity. Cytokine 10:290–294. (PMID: 961757410.1006/cyto.1997.0286) ; Shintani T, Rosli SNZ, Takatsu F, Choon YF, Hayashido Y, Toratani S, Usui E, Okamoto T (2016) Eldecalcitol (ED-71), an analog of 1α,25-dihydroxyvitamin D3 as a potential anti-cancer agent for oral squamous cell carcinomas. J Steroid Biochem Mol Biol 164:79–84. (PMID: 2644432510.1016/j.jsbmb.2015.09.043) ; Shintani T, Takatsu F, Rosli SNZ, Usui E, Hamada A, Sumi K, Hayashido Y, Toratani S, Okamoto T (2017) Eldecalcitol (ED-71), an analog of 1α,25(OH)(2)D(3), inhibits the growth of squamous cell carcinoma (SCC) cells in vitro and in vivo by down-regulating expression of heparin-binding protein 17/fibroblast growth factor-binding protein-1 (HBp17/FGFBP-1) and FGF-2. In Vitro Cell Dev Biol Anim 53:810–817. (PMID: 2871060210.1007/s11626-017-0183-9) ; Shintani T, Higaki M, Okamoto T (2021) Heparin-binding protein 17/fibroblast growth factor-binding protein-1 knockout inhibits proliferation and induces differentiation of squamous cell carcinoma cells. Cancers (Basel) 13:2684. ; Singh PK, van den Berg PR, Long MD, Vreugdenhil A, Grieshober L, Ochs-Balcom HM, Wang J, Delcambre S, Heikkinen S, Carlberg C, Campbell MJ, Sucheston-Campbell LE (2017) Integration of VDR genome wide binding and GWAS genetic variation data reveals co-occurrence of VDR and NF-κB binding that is linked to immune phenotypes. BMC Genomics 18:132. (PMID: 28166722529481710.1186/s12864-017-3481-4) ; Soutter AD, Nguyen M, Watanabe H, Folkman J (1993) Basic fibroblast growth factor secreted by an animal tumor is detectable in urine. Cancer Res 53:5297–5299. (PMID: 8221664) ; Sporn MB (2006) The early history of TGF-beta, and a brief glimpse of its future. Cytokine Growth Factor Rev 17:3–7. (PMID: 1629011010.1016/j.cytogfr.2005.09.012) ; Starska-Kowarska K (2023) Role of vitamin D in head and neck cancer-immune function, anti-tumour effect, and its impact on patient prognosis. Nutrients 15:2592. ; Tkach M, Théry C (2016) Communication by extracellular vesicles: where we are and where we need to go. Cell 164:1226–1232. (PMID: 2696728810.1016/j.cell.2016.01.043) ; Wang WP, Lehtoma K, Varban ML, Krishnan I, Chiu IM (1989) Cloning of the gene coding for human class 1 heparin-binding growth factor and its expression in fetal tissues. Mol Cell Biol 9:2387–2395. (PMID: 2474753362312) ; Wu DQ, Kan MK, Sato GH, Okamoto T, Sato JD (1991) Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors. J Biol Chem 266:16778–16785. (PMID: 188560510.1016/S0021-9258(18)55368-0) ; Yang J, Chen D, Tian G, Mao X, He J, Zheng P, Yu J, Luo Y, Luo J, Huang Z, Wu A, Yan H, Yu B (2022) 1,25-Dihydroxyvitamin D(3) negatively regulates the inflammatory response to porcine epidemic diarrhea virus infection by inhibiting NF-κB and JAK/STAT signaling pathway in IPEC-J2 porcine epithelial cells. Int J Mol Sci 23:10603. ; Yoshimura N, Sano H, Hashiramoto A, Yamada R, Nakajima H, Kondo M, Oka T (1998) The expression and localization of fibroblast growth factor-1 (FGF-1) and FGF receptor-1 (FGFR-1) in human breast cancer. Clin Immunol Immunopathol 89:28–34. (PMID: 975672110.1006/clin.1998.4551)
- Grant Information: 18H03000 Japan Society for the Promotion of Science; 19K11723 Japan Society for the Promotion of Science
- Contributed Indexing: Keywords: Fibroblast growth factor; Fibroblast growth factor-binding protein 1; Heparin-binding protein17; Squamous cell carcinoma (SCC); Vitamin D3
- Entry Date(s): Date Created: 20240507 Latest Revision: 20240507
- Update Code: 20240507
|
